Items tagged with Treatment
TB Alliance and partners announce world’s first availability of appropriate, child-friendly TB medicines in correct doses (post with simple image)
Medication simplifies and improves treatment for 1 million children with TB; Medicines come in dispersible fixed-dose combinations at the correct dosages, tablets no longer need to be cut or crushed; These products can improve adherence and child survival from TB.
New cohort study shows promise of dramatically shorter treatment option for multidrug-resistant TB (post with simple image)
Initial results show 80% success rate using 9-month treatment option for MDR-TB, compared with 24-month treatment standard.
Global progress and challenges in implementing new medications for treating multidrug-resistant tuberculosis (post with simple image)
Introducing bedaquiline and delamanid in TB programs worldwide has not kept pace with the need for these drugs. Coordinated global action might help assist making these medications accessible for persons who need them most.
Stop TB Partnership's Global Drug Facility jumpstarts access to new drugs for MDR-TB with innovative public-private partnerships (post with simple image)
The initiative will allow countries to access delamanid through the Stop TB Partnership’s Global Drug Facility at a price of US$ 1700 for each full-course treatment of six months’ duration.
Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments (post with simple image)
Médecins Sans Frontières released the 4th edition of its report DR-TB Drugs Under the Microscope. The report analyzes the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis.
Advocates call for WHO to update Delamanid Guidance to include children (post with simple image)
On World TB Day, and in light of new evidence of safety in children, advocates called on the World Health Organization to update its 2014 guidance on delamanid to include children.
STREAM Stage 2 Trial begins (post with simple image)
Stage 2 of trial aims to reduce MDR-TB treatment from 24 months to 6 or 9 months.
New Indian guidelines on the use of bedaquiline (post with simple image)
The Indian Ministry of Health and Family Welfare released Guidelines for use of Bedaquiline in RNTCP through conditional access under Programmatic Management of Drug Resistant Tuberculosis in India.
World Health Organization recommends shorter treatment for multidrug-resistant TB (post with simple image)
New World Health Organization recommendations aim to speed up detection and improve treatment outcomes for multidrug-resistant TB through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.
Page 52 of 55 · Total posts: 0←First 51 52 53 Last→